¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"allowable blood loss"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® blood vessel ÇÑ±Û Ç÷°ü
¼³¸í   
  Ç÷¾×ÀÌ ´Ù´Ï´Â ±æ. µ¿¸Æ, ¸ð¼¼Ç÷°ü, Á¤¸ÆÀ¸·Î ±¸¼ºµÈ´Ù. µ¿¸ÆÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°ü. À̰ÍÀº ½ÉÀå¿¡¼­ ³ª°¡´Â ÇǸ¦ ¿î¹ÝÇϴ Ç÷°üÀ̸砽ÉÀå¿¡¼­ Á÷Á¢ ¸¹Àº ¾Ð·ÂÀ» ¹Þ¾Æ¾ß ÇϹǷΠ¸¹Àº ¿¬Á¶Á÷°ú Åº¼º¼¶À¯·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. À̰ÍÀº Å©±â¿Í ±× Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ÙÀ½°ú °°ÀÌ ³ª´«´Ù. ´ëµ¿¸Æ(¿Þ½É½Ç¿¡¼­ Á÷Á¢ ³ª¿À´Â µ¿¸Æ. ¿Â¸öÀÇ Ç÷¾× ¼øÈ¯ÀÇ Áٱ⿪ÇÒÀ» ÇÑ´Ù), µ¿¸Æ(´ëµ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ Áß°£ Å©±âÀÇ µ¿¸Æ), ¼¼µ¿¸Æ(µ¿¸Æ¿¡¼­ ºÐÁö¸¦ ³½ ÀÛÀº µ¿¸ÆÀ» ¸»ÇÑ´Ù)À¸·Î ³ª´«´Ù.
  
  ¸ð¼¼Ç÷°ü(capillary)Àº ÇÑÃþÀÇ ¼¼Æ÷·Î ÀÌ·ç¾îÁø ¾ãÀº Ç÷°ü. À̰ÍÀ» ÅëÇØ¼­ ¿µ¾çºÐ°ú »ê¼ÒÀÇ À̵¿, ³ëÆó¹°ÀÇ À̵¿ µîÀÌ ÀÌ·ç¾îÁø´Ù.
  
  Á¤¸Æ(vein)Àº ½ÉÀåÀ¸·Î µé¾î¿À´Â Çǰ¡ È帣´Â Åë·Î. µ¿¸Æ¿¡ ºñÇØ¼­ Ç÷°üÀÇ º®ÀÌ ¾ã°í Ç÷¾×ÀÇ ¿ª·ù¸¦ ¹æÁöÇϱâ À§ÇÑ ÆÇ¸·ÀÌ Á¸ÀçÇϴ °ÍÀ̠Ư¡ÀÌ´Ù. À̰ÍÀº ½ÉÀå¿¡¼­ Á÷Á¢ ¾Ð·ÂÀ» ¹ÞÁö ¾Ê±â¶§¹®¿¡ Ç÷¾×ÀÌ ¿ª·ùÇÒ ¼öµµ ÀÖ°í ¶Ç Ç÷°üº®ÀÌ ¾ã¾Æµµ µÇ±â ¶§¹®ÀÌ´Ù. Å©±â¿Í Çö¹Ì°æÀû ±¸Á¶¿¡ µû¶ó ´ëÁ¤¸Æ(½ÉÀå°ú Á÷Á¢ ¿¬°áµÇ´Â Á¤¸Æ), Á¤¸Æ(´ëÁ¤¸Æ¿¡ À̸£±âÀü Áß°£ ±½±âÀÇ Á¤¸Æ), ¼¼Á¤¸Æ(¸ð¼¼Ç÷°ü°ú Á÷Á¢ ¿¬°áµÇ¾î Àִ ÀÛÀº ±½±âÀÇ Á¤¸Æ)À¸·Î ³ª´«´Ù.
  
  Ç÷°ü
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood sugar ÇÑ±Û Ç÷´ç
¼³¸í   
  Ç÷¾× ¼Ó¿¡ Æ÷ÇԵǾî Àִ Æ÷µµ´ç. ³ú¿Í ÀûÇ÷±¸ÀÇ ¿¡³ÊÁö¿øÀÌ µÇ°í, ±× ¾çÀº ¿îµ¿, ½Ä»ç µûÀ§¿¡ ÀÇÇÏ¿© ´Þ¶óÁø´Ù. °Ç°­ÀÎÀÇ ¾ÆÄ§ °øº¹½Ã Ç÷Áß Æ÷µµ´ç ³óµµ´Â 60~100mg/dL ÀÌÁö¸¸ ±âŸÀÇ ´çÁú Áï °ú´ç, °¥¶ôÅ佺, 5ź´çÀº ¹Ì·®À̸ç ÀϹÝÀûÀ¸·Î Ç÷´çÀ̶ó Çϸé Ç÷Á߯÷µµ´çÀ» ÀǹÌÇÑ´Ù. Ç÷´çÀº »ýüÀÇ ¿¡³ÊÁö¿øÀ¸·Î¼­ °¡Àå Áß¿äÇÑ ¹°ÁúÀÌ´Ù. ±× ³óµµ´Â Àå°üÀ¸·ÎºÎÅÍÀÇ Èí¼ö, °£¿¡ À־ÀÇ ´ç½Å»ý°ú ±Û¸®ÄÚ°ÕÀÌ ÇÕ¼º-ºÐÇØ, ¸»ÃÊÁ¶Á÷ÀÇ ´çÀÌ¿ë ÄáÆÏÀ¸·ÎºÎÅÍÀÇ ¹è¼³ µî ¿©·¯ ÀÎÀÚ¿¡ ÀÇÇØ Á¿ìµÇ¸ç ±× Á¶Àý¿¡´Â ÀÚÀ²½Å°æ°ú °¢Á¾ È£¸£¸óÀÌ ¹ÐÁ¢ÇϰԠ°ü°èÇÑ´Ù. Æ¯È÷ Ç÷´çÀúÇÏÀÛ¿ë¿¡´Â Àν¶¸°ÀÌ, ±×¸®°í Ç÷´ç»ó½ÂÀÛ¿ë¿¡´Â ¿¡Çdz×ÇÁ¸°, ±Û·çÄ«°ï, ¼ºÀåÈ£¸£¸ó, ºÎ½Å°ÑÁúÈ£¸£¸ó, ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó, °©»ó»ù È£¸£¸óÀÌ °ü°è°¡ ÀÖÀ¸¸ç ±×°ÍµéÀÇ ´ëÇ× ¹× ÇùÁ¶ÀÛ¿ë¿¡ ÀÇÇØ Ç÷´çÄ¡°¡ Á¶ÀýµÈ´Ù.
¿µ¹® blood pressure ÇÑ±Û Ç÷¾Ð
¼³¸í   
  Ç÷¾ÐÀ̶õ Ç÷°ü¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϴ °ÍÀ¸·Î ´ë°³ Æ¯º°ÇÑ ¼³¸íÀÌ ¾øÀ¸¸é µ¿¸ÆÀÇ ¾Ð·ÂÀ» ¸»ÇÑ´Ù. Ç÷¾Ð¿¡´Â ¼öÃà±âÇ÷¾Ð(systolic blood pressure)°ú À̿ϱâÇ÷¾Ð(diastolic blood pressure)ÀÌ ÀÖ´Ù. ¼öÃà±âÇ÷¾ÐÀ̶õ ½ÉÀåÀÌ ¼öÃàÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»Çϰí, À̿ϱâ Ç÷¾ÐÀ̶õ ½ÉÀåÀÌ ÀÌ¿ÏÇÒ °æ¿ì¿¡ µ¿¸Æ¿¡ °É¸®´Â ¾Ð·ÂÀ» ¸»ÇÑ´Ù. ´ç¿¬È÷ ¼öÃà±â Ç÷¾ÐÀÌ À̿ϱâ Ç÷¾Ðº¸´Ù ³ô´Ù. Ç÷¾ÐÀ» ¸»ÇÒ ¶§¿¡ ¿¹¸¦ µé¾î 120/80mmHgÀ̶ó°í Àû´Â °ÍÀÇ ¾ÕÀÇ °ÍÀº ¼öÃà±â Ç÷¾ÐÀ» ÀǹÌÇÏ°í µÚ¿¡ Àû´Â 80Àº À̿ϱâ Ç÷¾ÐÀ» ÀǹÌÇÑ´Ù.
¿µ¹® blood ÇÑ±Û Ç÷¾×, ÇÇ
¼³¸í   
  ¼øÈ¯±â, Áï ½ÉÀå°ú Ç÷°ü ¾ÈÀ» ¼øÈ¯Çϴ À¯µ¿¼ºÀÇ Á¶Á÷À» ¸»ÇÑ´Ù. Ç÷¾×Àº Àüü Ã¼ÁßÀÇ ¾à 8%¸¦ Â÷ÁöÇϸç, ºñÁßÀº 1,056~1,059, Á¡µµ´Â ¾à 4.5, pH´Â 7.4ÀÌ´Ù. Ç÷¾×Àº ¾×ü¼ººÐÀΠÇ÷Àå°ú °Å±â¿¡ ¶°µ¹°í Àִ ¼¼Æ÷¼ººÐÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. Ç÷ÀåÀº Àüü Ç÷¾×ÀÇ 55%¸¦ Â÷ÁöÇϸ砼öºÐ, ´Ü¹éÁú, Ç÷´ç, Áö¹æÁú, ¹«±â¿°·ù, Áú¼ÒÈ­ÇÕ¹°·Î ÀÌ·ç¾îÁø´Ù. ¼¼Æ÷¼ººÐÀº Àüü Ç÷¾×ÀÇ 45%¸¦ Â÷ÁöÇϸç ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇÀ¸·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. Ç÷¾×ÀÇ ÁÖ¿ä ±â´ÉÀº Àü½Å Á¶Á÷À¸·Î »ê¼Ò¿Í ¿µ¾çºÐ °°Àº ÇÊ¿äÇÑ ¹°ÁúÀ» ¿î¹ÝÇϸ砺ÒÇÊ¿äÇÑ ¹°ÁúÀ» ¹è¼³±â°üÀ¸·Î ¿î¹ÝÇϴ ÀÏÀÌ´Ù. ±× ¹Û¿¡ »ýü¿¡ Çطο°ÁúÀ̳ª ¼¼±ÕÀ» Á¦°ÅÇϰí, ³»ºÎȯ°æÀÇ Çâ»ó¼ºÀ» À¯ÁöÇϸç, Ã¼¿ÂÀ¯Áö¿Í »ýü ¹æ¾î ±â´ÉÀ» ÇÑ´Ù. »ç¶÷ÀÇ Ç÷¾×Àº ¿©·¯ °¡Áö ¼¼Æ÷ Ç÷±¸¿Í ±× ¼¼Æ÷¸¦ Æ÷ÇÔÇϴ ¸¼Àº ¾×üÀΠÇ÷Àå·Î ±¸¼ºµÇ¾î ÀÖ´Ù. Ç÷±¸´Â ÀûÇ÷±¸, ¹éÇ÷±¸, Ç÷¼ÒÆÇÀ¸·Î ±¸¼ºµÇ¾î ÀÖ´Ù. ÀûÇ÷±¸´Â ºÓÀº »öÀ» ¶ì´Â ¼¼Æ÷·Î »ê¼Ò¸¦ ¸öÀÇ Á¶Á÷À¸·Î ¿î¹ÝÇϴ ¿ªÇÒÀ» ÇÑ´Ù. Ç÷¼ÒÆÇÀº Ç÷¾×ÀÀ°í¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϴ ¼¼Æ÷ÀÌ´Ù.
  
  ¹éÇ÷±¸´Â Àΰ£ÀÇ ¸é¿ª¿¡ °ü°èÇϴ ¼¼Æ÷À̸砱¸Ã¼ÀûÀ¸·Î ´ÙÀ½°ú °°Àº ¼¼Æ÷µéÀÌ ÀÖ´Ù.
  
  1.°ú¸³±¸(granulocyte): °ú¸³±¸¶õ ¹éÇ÷±¸ÀÇ 60%¸¦ Â÷ÁöÇϸç, ¼¼Æ÷¼Ó¿¡ Æ¯ÀÌÇÑ °ú¸³À» °¡Áö°í Àִ ¼¼Æ÷À̸ç, ´ÙÀ½°ú °°Àº 3°¡ÁöÀÇ ¼¼Æ÷°¡ À̰÷¿¡ Æ÷ÇÔÀÌ µÈ´Ù.
  
    -È£¿°±â±¸(basophil): ¿°±â¼º¿°»ö¾à¿¡ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö°í ÀÖ´Ù. ºÒ±ÔÄ¢ÇÑ ¸ð¾çÀÇ ¼¼Æ÷·Î Çª¸¥ »öÀ» ¶ì´Â °ú¸³ÀÌ ³Ê¹« ¸¹ÀÌ À־ ÇÙÀÌ Àß º¸ÀÌÁö ¾Ê´Â´Ù.
  
    -È£»ê±¸(eosinophil): »ê¼º¿°»ö¾à¿¡ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö°í ÀÖ°í, ´ë°³ ±â»ýÃæÀÇ °¨¿°À̳ª, ¾Ë·¯Áö¿¡¼­ ¸¹ÀÌ Áõ°¡ÇÑ´Ù. ´ë°³ 2°³ÀÇ ÇÙÀ» °¡Áö°í ÀÖÀ¸¸ç ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº °ÍÀ¸·Î À̾îÁ® ÀÖ´Ù.
  
    -È£Áß±¸(neutrophil): »ê¼º¿°»ö¾àÀ̳ª ¿°±â¼º¿°»ö¾à¿¡ ÀÇÇÏ¿© ¸ðµÎ Àß ¿°»öµÇ´Â °ú¸³À» °¡Áö´Â ¼¼Æ÷·Î ´ë°³ 3°³ÀÇ ÇÙÀ» °¡Áø´Ù. ±×¸®°í ÇÙ»çÀÌ¿¡ °¡´Â ½Ç°°Àº ±¸Á¶¹°ÀÌ À־ ÇÙÀ» ¼­·Î À̾îÁÖ°í ÀÖ´Ù.
  
  2.´ÜÇÙ±¸(monocyte): ´Ù°¢Çü¸ð¾çÀ» °¡Áø ¼¼Æ÷·Î °ú¸³À» °¡Áö°í ÀÖÁö ¾Ê´Ù. ¿Ü°è·ÎºÎÅÍ µé¾î¿Â ¹°ÁúÀ» Àâ¾Æ¸Ô´Â ¿ªÇÒ°ú ±×°Í¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇϴ ¿ªÇÒÀ» ÇÏ¿© ¸é¿ª¿¡ °ü°èÇÑ´Ù. À̰ÍÀÌ Ç÷¾× Áß¿¡ Á¸ÀçÇÏÁö ¾Ê°í Á¶Á÷¿¡ °íÁ¤µÇ¾î Àִ °æ¿ì¿¡ À̰ÍÀ» Å«Æ÷½Ä¼¼Æ÷¶ó°í ÇÑ´Ù.
  
  3.¸²ÇÁ±¸(lymphocyte): ÀÛÀº ¿øÇüÀÇ ¼¼Æ÷·Î ¸é¿ª¿¡ ÁßÃßÀûÀΠ¿ªÇÒÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heat loss
    ¿­¼Õ½Ç
  • high velocity signal loss
    °í¼Ó½ÅÈ£¼Ò½Ç
  • ionization loss
    ÀÌ¿ÂÈ­¼Õ½Ç
  • idiopathic sudden hearing loss
    Ư¹ßµ¹¹ß³­Ã», Ư¹ß°©ÀÛ³­Ã»
  • insensible loss
    ºÒ°¨»ó½Ç
  • loss
    »ó½Ç, ¼Õ½Ç, ¼Ò½Ç
  • loss-of-function mutation
    ±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
  • mixed hearing loss
    È¥ÇÕ³­Ã»
  • neonatal hair loss
    ½Å»ý¾ÆÅ»¸ð
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • occupational hearing loss
    Á÷¾÷³­Ã»
  • obligatory water loss
    ÇÊ¿¬¼öºÐ¼Õ½Ç
  • organic visual loss
    ±âÁú½Ã°¢»ó½Ç
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood concentration
    Ç÷Áß³óµµ
  • blood collection
    äÇ÷
  • blood cell
    Ç÷¾×¼¼Æ÷, Ç÷±¸
  • blood count
    Ç÷±¸°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • packed red blood cell
    ³óÃàÀûÇ÷±¸
  • red blood cell
    ÀûÇ÷±¸
  • red blood corpuscle
    ÀûÇ÷±¸
  • white blood corpuscle
    ¹éÇ÷±¸
  • blood donor
    ÇåÇ÷ÀÚ, °øÇ÷ÀÚ
  • blood donation
    ÇåÇ÷
  • blood film examination
    Ç÷¾×Æì¹Ù¸¥°Ë»ç, Ç÷¾×µµ¸»°Ë»ç
  • blood film
    Ç÷¾×Æì¹Ù¸¥Ç¥º», Ç÷¾×µµ¸»
  • blood flow
    Ç÷·ù
  • blood pressure fluctuation
    Ç÷¾Ðº¯µ¿, Ç÷¾Ð±âº¹
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • functional hearing loss
    ±â´É³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç
  • heat loss
    ¿­¼Õ½Ç
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
  • idiopathic sudden hearing loss
    Ư¹ßµ¹¹ß³­Ã», Ư¹ß°©ÀÛ³­Ã»
  • mixed hearing loss
    È¥ÇÕ³­Ã»
  • noise induced hearing loss
    ¼ÒÀ½³­Ã»
  • occupational hearing loss
    Á÷¾÷³­Ã»
  • perceptive hearing loss
    °¨À½³­Ã», Áö°¢³­Ã»
  • retrolabyrinthine hearing loss
    ¹Ì·ÎµÚ³­Ã»
  • sensorineural hearing loss
    °¨°¢½Å°æ³­Ã»
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
  • insensible loss
    ºÒ°¨»ó½Ç
  • ionization loss
    ÀÌ¿ÂÈ­¼Õ½Ç
  • loss
    ¼Õ½Ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hearing loss, idiopathic sudden
    Ư¹ß¼º µ¹¹ß(¼º)³­Ã»
  • hearing loss, mixed
    È¥ÇÕ(¼º) ³­Ã»
  • hearing loss, noise induced
    ¼ÒÀ½¼º³­Ã»
  • hearing loss, occupational
    Á÷¾÷¼º³­Ã»
  • hearing loss, perceptive
    °¨À½³­Ã»
  • hearing loss, sensorineural
    °¨°¢½Å°æ¼º ³­Ã»
  • hearing loss, speech
    ¾îÀ½Ã»·Â¼Õ½Ç
  • heat loss
    ¿­¼Õ½Ç(ËçËÛËà).
  • heating loss
    °¡¿­°¨·®(¡­ÊõåÖ).
  • high velocity signal loss
    °í¼Óµµ ½ÅÈ£ ¼Ò½Ç
  • idiopathic sudden hearing loss
    Ư¹ß¼º µ¹¹ß(¼º)³­Ã»
  • insensible loss
    ºÒ°¨»ó½Ç(¡­ßÃã÷).
  • insensible water loss
    ºÒ°¨¼º(ÝÕÊïàõ) ¼öºÐ»ó½Ç(â©ÝÂßÃã÷).
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • ABO blood group
    ABO Ç÷¾×Çü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell loss factor
    ¼¼Æ÷¼Ò½Ç°è¼ö
  • central hearing loss
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã».
  • collision loss
    Ãæµ¹¼Õ½Ç
  • condensed milk conductive hearing loss
  • conductive hearing loss
    ÀüÀ½¼º Àüµµ¼º ³­Ã»
  • congenital hearing loss
    ³­Ã»
  • discrimination loss
    ¾îÀ½ÆÇº°¼Õ½Ç
  • economic loss
    °æÁ¦Àû ¼Õ½Ç.
  • evaporation loss
    Áõ¹ß¼Õ½Ç(¡­áßã÷).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • gastrointestinal loss
  • hearing loss
    °¨°¢½Å°æ(¼º) ³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Blood cells
    Ç÷¾×¼¼Æ÷ [Ç÷±¸]
    [¿¾ ¿ë¾î] Ç÷¾×¼¼Æ÷
  • Blood
    Ç÷¾× (ÇÇ)
    [¿¾ ¿ë¾î] Ç÷¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Rh blood group system
    Rh Ç÷¾×Çü(úìäûúþ) ½Ã½ºÅÛ
  • whole blood
    ÀüÇ÷(îïúì)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood oxygenation level dependant [=BOLD]
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸
  • blood oxygenation level dependant contrast
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸´ëÁ¶µµ
  • blood pool scan
    Ç÷¾×Àú·ùÁÖ»ç
  • blood stained
    ÇǼ¯ÀÎ, Çǹ¯Àº
  • blood stream
    Ç÷·ù
  • blood sugar
    Ç÷´ç
  • blood supply
    Ç÷¾×°ø±Þ
  • blood vessel
    Ç÷°ü, ÇÍÁÙ
  • blood volume
    Ç÷¾×¾ç
  • BOLD [=blood oxygenation level dependent]
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸
  • bright blood imaging
    ¸íÇ÷·ù¿µ»ó
  • cord blood
    Á¦´ëÇ÷¾×
  • electromagnetic blood flowmeter
    ÀüÀÚ±âÇ÷·ùÃøÁ¤±â
  • fat blood level
    Áö¹æÇ÷Ãþ
  • liver blood flow
    °£ÀåÇ÷¾×À¯Åë, °£Ç÷·ù
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HBF hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala...
MAC   1) Maximal Allowable Concentration
  2) MTX, Actinomycin-D, Cyclophosphamid...
TLV-C Threshold Limit Value-Ceiling
  = MAC(Maximum Allowable Concentration)
  ...
ADI Academy of Dentistry International; acceptable daily intake; AIDS-defining illness; allowable daily ...
ALE active life expectancy; allowable limits of error; amputated lower extremity
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CLV Corrected Loss Variance
EELS Electron Energy Loss Spectroscopy
EWL Evaporative water loss
EWL Excess Weight Loss
G-LOC G(z)-induced loss of consciousness
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • loss of appetite
    ½Ä¿å ºÎÁø
  • loss of consciousness
    ÀÇ½Ä »ó½Ç
  • loss of gloss
    ±¤ÅÃÀÇ ¼Ò½Ç
  • loss of molar support
    ±¸Ä¡ºÎ ÁöÁöÀÇ »ó½Ç
  • loss of structural integrity
    ±¸Á¶ÀûÀÎ ¿ÏÀü¼ºÀÇ »ó½Ç
  • patchy loss
    ¹Ý¼º »ó½Ç
  • sensorineural hearing loss
    °¨°¢ ½Å°æ¼º ³­Ã»
  • sensory hearing loss
    °¨°¢¼º ³­Ã»
    ¿Í¿ì
  • signal loss
    ½ÅÈ£ ¼Ò½Ç
  • weight loss
    üÁß °¨¼Ò
    ´Ü½Ä, ½ÄÀÌÁ¶Àý, º´À¸·Î ÀÎÇØ ³ªÅ¸³ª¸ç, üÁö¹æÀÇ °¨¼Ò ¶Ç´Â À½½Ä¼·Ãë ºÎÁ·À¸·Î ÀÎÇÑ ¿µ¾ç°áÇÌ ½Ã¿¡ ³ªÅ¸³­´Ù.
  • ABO blood group system
    ABO Ç÷¾×Çü°è, ABO Ç÷¾×Çü °èÅë
    A, B´Â ¿ì¼º, O´Â ¿­¼ºÀ¸·Î¼­, A, B, AB, OÇüÀÌ ÀÖ´Ù.
  • arterial blood gas
    µ¿¸ÆÇ÷ °¡½º ºÐ¾Ð
  • arterial blood gas study
    µ¿¸ÆÇ÷ °³½º ºÐ¾Ð ÃøÁ¤
  • artificial blood vessel
    Àΰø Ç÷°ü
  • autoimmune blood dyscrasia
    ÀÚ°¡ ¸é¿ª¼º Ç÷¾× ÀÌ»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hearing loss, partial A condition in which the sense of hearing, although defective, is functional with or without a hearing aid. The hearing level for speech is approximately 40-70 decibels I.s.o. (international organization for standardization) or 30-60 db a.s.a. (american standards association).
(12 Dec 1998)
hearing loss, sensorineural Hearing loss resulting from damage to the sensory mechanism internal from the oval and round windows.
(12 Dec 1998)
sensorineural hearing loss <neurology> A form of deafness that occurs due to dysfunction of the auditory nerve (cranial nerve VIII).
(27 Sep 1997)
drift cyclotron loss cone instabilities (DCLC) This is an electrostatic microinstability (frequencies at harmonics of the ion cyclotron frequency) which is of major concern in small mirror devices. Mode is driven by radial gradients in the electron density, and causes loss of ions due to non-conservation of magnetic moment (see adiabatic invariant) as they interact with the mode, and are dispersed in velocity space into the loss cone. Stabilisation is accomplished by increasing the plasma size and by partially filling the loss cone with a continuous extermal warm plasma stream.
(09 Oct 1997)
eddy-current loss <radiobiology> Energy loss due to eddy currents circulating in a resistive material.
(09 Oct 1997)
tooth loss The failure to retain teeth as a result of disease or injury.
(12 Dec 1998)
functional visual loss An apparent loss of visual acuity or visual field with no substantiating physical signs; often due to a natural concern about visual loss combined with suggestibility and a fear of the worst; best treated with reassurance.
(05 Mar 2000)
loss cone In a magnetic mirror machine, particles with a large velocity parallel to the magneitc field and a small velocity perpendicular to the field will be able to escape past the magnetic mirror (see magnetic mirror). In that case the velocity distribution function (see distribution function) will be almost zero in the region of velocity space that allows particles to escape. The shape of that region (in a velocity space diagram with parallel velocity and perpendicular velocity as the axes) is a cone. When a particle undergoes a collision, its velocity gets somewhat randomised. Particles that are scattered into that cone are lost very quickly (in one mirror bounce time). Thus it is called a loss cone. Because of the loss cone, the theoretical maximum particle confinement time of a magnetic mirror machine can be only a few times the particle collision time, this is generally seen as a showstopper for mirror-based fusion research.
(09 Oct 1997)
loss of consciousness Total unresponsiveness. An important neurologic sign.
(27 Sep 1997)
loss of heterozygosity Refers to a mutation that results in the loss of allelic uniqueness, which is often defined as a greater than or equal to 40 percent increase in signal intensity of allelic signal. Loss of heterozygosity is most frequently identified in certain chromosome regions, including 5q, 17p, and 18q.
(12 Dec 1998)
ABO blood group <haematology> The major human blood type system which describes the oligosaccharide glycoprotein antigens found on the surface of human blood cells.
According to the type of antigen present, a person may be assigned a blood type of A, B, AB or O. A second type of antigen, the Rh factor, renders a positive or negative blood type. The ABO blood group system is important because it determines who can donate blood to or accept blood from whom.
Type A or AB blood will cause an immune reaction in people with type B blood and type B and AB blood will cause a reaction in people with type A blood.
Conversely, type O blood has no A or B antigens, so people with type O blood are universal donors.
And since AB blood already produces both antigens, people who are type AB can accept any of the other blood types without suffering an immune reaction.
(04 Jul 1999)
Almen's test for blood Glacial acetic acid, gum guaiac solution, and hydrogen peroxide are added to an aqueous suspension of the suspected stain; if occult blood or blood pigment is present, a blue colour develops.
Synonym: guaiac test, Schonbein's test, van Deen's test.
(05 Mar 2000)
arterial blood Blood that is oxygenated in the lungs, found in the left chambers of the heart and in the arteries, and relatively bright red.
(05 Mar 2000)
arterial blood gas A test which analyses arterial blood for oxygen, carbon dioxide and bicarbonate content in addition to blood pH. Used to test the effectiveness of respiration.
Acronym: ABG
(17 Oct 1997)
blood <haematology> Considered a circulating tissue composed of a fluid portion (plasma) with suspended formed elements (red blood cells, white blood cells, platelets).
Arterial blood is the means by which oxygen and nutrients are transported to tissues, venous blood is the means by which carbon dioxide and metabolic by-products are transported for excretion.
(05 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • blood cell
    Ç÷±¸
  • blood clot
    Ç÷º´;Ç÷±«
  • blood count
    Ç÷±¸¼öÃøÁ¤
  • blood donor
    ÇåÇ÷ÀÚ
  • blood group
    Ç÷¾×Çü Á¤
  • blood heat
    Ç÷¿Â(Àΰ£ÀÇ Ç¥ÁØ Ã¼¿Â,º¸Åë 37µµ)
  • blood money
    »ìÀλç·Ê±Ý;(Àû±â¸¦ °ÝÃßÇÑ ÀÚ¿¡°Ô ÁÖ´Â)°ø·Î±Ý;À§ÀÚ·á
  • blood poisoning
    ÆÐÇ÷Áõ
  • blood pressure
    Ç÷¾Ð
  • blood relation
    Ç÷Á·
  • blood royal
    ¿ÕÁ·
  • blood test
    Ç÷¾×°Ë»ç
  • blood transgusion
    ¼öÇ÷¹ý !
  • blood vessel
    Ç÷°ü öÇ
  • blue blood
    ¸í¹®(ÇǺΰ¡ Èñ°í Á¤¸ÆÀÌ ºñÃÄ º¸ÀÌ´Â µ¥¼­);±ÍÁ·
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á